Akron's net profit under IFRS in the first half of 2024 amounted to RUB 18.68 billion. This is 2% less than in the same period of 2023. In dollar terms, net profit decreased by 17% to $206 million.

For the trailing twelve-month period ended September 28, 2024, net revenues were $11.5 billion (revenues were $15.2 billion), ...

Gogoro Inc. ("Gogoro," "the Company" or "We") (Nasdaq: GGR), a global technology leader in battery swapping ecosystems that enable ...

For a reconciliation of Adjusted Earnings Per Share, investors should refer to Vecima’s Management’s Discussion and Analysis for the second quarter of fiscal 2025. 4 Adjusted earnings per share ...

Record Revenue, $53.7m Operating Cashflow, $18.9m NPAT75MW Liquid-Cooled Childress Data Center for AI / HPC (“Horizon 1”)Developing New 600MW ...

NanoXplore reports its financials in two distinct segments: Advanced Materials, Plastics and Composite Products and Battery Cells. Revenues from customers increased from $28,559,390 in Q2-2024 to ...

PyroGenesis Inc. (“PyroGenesis”) ( (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a high-tech company that designs, develops, ...

NanoXplore Inc. ("NanoXplore" or "the Corporation") (TSX: GRA and OTCQX: NNXPF), a world-leading graphene company, reported today financial results for the ...

Q3 2025 Earnings Call Transcript February 12, 2025 Operator: Hello, everyone. Welcome to today’s webcast on HIVE Digital ...

Converge Technology Solutions Corp. ("Converge" or "the Company") (TSX: CTS) (FSE: 0ZB) (OTCQX: CTSDF), today announced preliminary results for the fourth quarter ("Q4-2024") and fiscal year ended ...

Q4 2024 Earnings Call Transcript February 13, 2025 ASE Technology Holding Co., Ltd. misses on earnings expectations. Reported ...

Sanofi announces update on extraintestinal pathogenic E. coli vaccine phase 3 clinical study: Paris Friday, February 14, 2025, 12:00 Hrs [IST] A scheduled review of the E.mbrace p ...